These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9343827)

  • 1. Role of curdlan sulfate in the binding of HIV-1 gp120 to CD4 molecules and the production of gp120-mediated TNF-alpha.
    Takeda-Hirokawa N; Neoh LP; Akimoto H; Kaneko H; Hishikawa T; Sekigawa I; Hashimoto H; Hirose S; Murakami T; Yamamoto N; Mimura T; Kaneko Y
    Microbiol Immunol; 1997; 41(9):741-5. PubMed ID: 9343827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of curdlan sulfate in the production of beta-chemokines and interleukin-16.
    Naito T; Takeda-Hirokawa N; Kaneko H; Sekigawa I; Matsumoto T; Hashimoto H; Kaneko Y
    Med Microbiol Immunol; 1998 Jun; 187(1):43-8. PubMed ID: 9749981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro.
    Jagodzinski PP; Wiaderkiewicz R; Kurzawski G; Kloczewiak M; Nakashima H; Hyjek E; Yamamoto N; Uryu T; Kaneko Y; Posner MR
    Virology; 1994 Aug; 202(2):735-45. PubMed ID: 7913276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of curdlan sulfate on the production of beta-chemokines and cytokines.
    Takeda-Hirokawa N; Neoh LP; Akimoto H; Kaneko H; Hishikawa T; Hashimoto H; Sekigawa I; Hirose S; Yamanoto N; Kaneko Y
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):723-5. PubMed ID: 9643371
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha.
    Karsten V; Gordon S; Kirn A; Herbein G
    Immunology; 1996 May; 88(1):55-60. PubMed ID: 8707350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding.
    Wang HG; Williams RE; Lin PF
    Curr Pharm Des; 2004; 10(15):1785-93. PubMed ID: 15180540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
    Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions.
    Guo Q; Ho HT; Dicker I; Fan L; Zhou N; Friborg J; Wang T; McAuliffe BV; Wang HG; Rose RE; Fang H; Scarnati HT; Langley DR; Meanwell NA; Abraham R; Colonno RJ; Lin PF
    J Virol; 2003 Oct; 77(19):10528-36. PubMed ID: 12970437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of HIV-1 gp120 molecule fragments with human monocytes: different requirements for tumor necrosis factor-alpha and IL-6 production.
    Zembala M; Pryjma J; Plucienniczak A; Szczepanek A; Jasinski M; Ruggiero I; Piselli P; Colizzi V
    Clin Immunol Immunopathol; 1995 May; 75(2):131-9. PubMed ID: 7704970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways.
    Lee C; Tomkowicz B; Freedman BD; Collman RG
    J Leukoc Biol; 2005 Oct; 78(4):1016-23. PubMed ID: 16081599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced human immunodeficiency virus infection in macrophages by high-molecular-weight dextran sulfate is associated with conformational changes of gp120 and expression of the CCR5 receptor.
    Jagodzinski PP; Wierzbicki A; Wustner J; Kaneko Y; Kozbor D
    Viral Immunol; 1999; 12(1):23-33. PubMed ID: 10333239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes.
    Clancy J; Tait-Kamradt A; Petitpas J; Manousos M; McGuirk PR; Subashi T; Watts P; Wondrack L
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2008-13. PubMed ID: 7811011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the antiretroviral effects of a PEG-conjugated peptide derived from human CD38.
    Bensi T; Mele F; Ferretti M; Norelli S; El Daker S; Chiocchetti A; Maria Rojo J; Cauda R; Dianzani U; Savarino A
    Expert Opin Ther Targets; 2009 Feb; 13(2):141-52. PubMed ID: 19236233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumour necrosis factor-alpha (TNF-alpha) in the induction of HIV-1 gp120-mediated CD4+ T cell anergy.
    Kaneko H; Hishikawa T; Sekigawa I; Hashimoto H; Okumura K; Kaneko Y
    Clin Exp Immunol; 1997 Jul; 109(1):41-6. PubMed ID: 9218822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
    Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
    J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4.
    Furci L; Sironi F; Tolazzi M; Vassena L; Lusso P
    Blood; 2007 Apr; 109(7):2928-35. PubMed ID: 17132727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.